BerandaOCEAW • NASDAQ
add
Ocean Biomedical
Tutup sebelumnya
$0,029
Rentang hari
$0,026 - $0,030
Rentang tahun
$0,020 - $0,68
Kapitalisasi pasar
5,07 jt USD
Volume Rata-Rata
74,35 rb
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 768,00 rb | -71,07% |
Laba bersih | -5,53 jt | 60,76% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | — | — |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | — | — |
Total aset | 1,13 jt | 9,80% |
Total liabilitas | 99,22 jt | 30,11% |
Total ekuitas | -98,08 jt | — |
Saham yang beredar | 34,87 jt | — |
Harga terhadap nilai buku | -0,01 | — |
Tingkat pengembalian aset | -128,73% | — |
Tingkat pengembalian modal | 2,46% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -5,53 jt | 60,76% |
Kas dari operasi | -885,00 rb | 21,68% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 896,00 rb | — |
Perubahan kas bersih | 11,00 rb | 100,97% |
Arus kas bebas | 1,62 jt | 294,11% |
Tentang
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Didirikan
2019
Kantor pusat
Situs
Karyawan
7
